SYENSQO SA/NV |
Market Closed -
Other stock markets
|
After market 03:27:13 pm | |||
| 94.61 EUR | +0.37% |
|
94.72 | +0.12% |
| May. 06 | Syensqo: CEO appointed to head chemical federation | CF |
| Apr. 29 | Syensqo: completes acquisition of South Korean JinYoung Bio | CF |
Valuation
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Capitalization 1 | 9,980 | 9,955 | - | - |
| Enterprise Value (EV) 1 | 11,564 | 11,249 | 11,059 | 10,864 |
| P/E ratio | 51.8 x | 16.4 x | 13.6 x | 11.9 x |
| Yield | 1.72% | 1.73% | 1.89% | 2.01% |
| Capitalization / Revenue | 1.46 x | 1.46 x | 1.37 x | 1.3 x |
| EV / Revenue | 1.69 x | 1.65 x | 1.53 x | 1.42 x |
| EV / EBITDA | 7.15 x | 7.61 x | 6.78 x | 6.17 x |
| EV / FCF | 25.8 x | 33 x | 25.4 x | 22.4 x |
| FCF Yield | 3.87% | 3.03% | 3.94% | 4.47% |
| Price to Book | 1.32 x | 1.25 x | 1.18 x | 1.09 x |
| Nbr of stocks (in thousands) | 105,876 | 105,221 | - | - |
| Reference price 2 | 94.26 | 94.26 | 94.26 | 94.26 |
| Announcement Date | 3/12/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net sales 1 | 6,834 | 6,835 | 7,243 | 7,650 |
| EBITDA 1 | 1,618 | 1,479 | 1,631 | 1,762 |
| EBIT 1 | 1,134 | 993.2 | 1,117 | 1,237 |
| Operating Margin | 16.59% | 14.53% | 15.42% | 16.17% |
| Earnings before Tax (EBT) 1 | 389 | 811.5 | 947.7 | 1,093 |
| Net income 1 | 193 | 600.9 | 722.9 | 816.9 |
| Net margin | 2.82% | 8.79% | 9.98% | 10.68% |
| EPS 2 | 1.820 | 5.759 | 6.927 | 7.944 |
| Free Cash Flow 1 | 448 | 340.8 | 436.2 | 485.8 |
| FCF margin | 6.56% | 4.99% | 6.02% | 6.35% |
| FCF Conversion (EBITDA) | 27.69% | 23.05% | 26.74% | 27.57% |
| FCF Conversion (Net income) | 232.12% | 56.71% | 60.35% | 59.46% |
| Dividend per Share 2 | 1.620 | 1.632 | 1.780 | 1.897 |
| Announcement Date | 3/12/24 | - | - | - |
1EUR in Million2EUR
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2023 Q4 | 2023 S2 | 2024 Q1 | 2024 Q2 | 2024 S1 | 2024 Q3 | 2024 Q4 | 2024 S2 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,577 | - | 1,615 | 1,785 | 3,418 | 1,753 | 1,736 | 3,489 |
| EBITDA 1 | 294 | - | 354.3 | - | - | - | - | - |
| EBIT 1 | - | 457 | 232 | - | - | - | - | - |
| Operating Margin | - | - | 14.36% | - | - | - | - | - |
| Earnings before Tax (EBT) | - | 59 | - | - | - | - | - | - |
| Net income | - | -106 | - | - | - | - | - | - |
| Net margin | - | - | - | - | - | - | - | - |
| EPS | - | - | - | - | - | - | - | - |
| Dividend per Share | - | - | - | - | - | - | - | - |
| Announcement Date | 3/12/24 | 3/12/24 | - | - | - | - | - | - |
1EUR in Million
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|
| Net Debt 1 | 1,584 | 1,294 | 1,104 | 909 |
| Net Cash position 1 | - | - | - | - |
| Leverage (Debt/EBITDA) | 0.979 x | 0.8749 x | 0.6766 x | 0.5157 x |
| Free Cash Flow 1 | 448 | 341 | 436 | 486 |
| ROE (net income / shareholders' equity) | 12% | 8.23% | 9.29% | 9.59% |
| ROA (Net income/ Total Assets) | 5.67% | 4.59% | 5.7% | 6.1% |
| Assets 1 | 3,404 | 13,089 | 12,689 | 13,389 |
| Book Value Per Share 2 | 71.50 | 75.20 | 80.10 | 86.40 |
| Cash Flow per Share 2 | 12.00 | 8.830 | 11.20 | 12.30 |
| Capex 1 | 848 | 651 | 773 | 803 |
| Capex / Sales | 12.41% | 9.53% | 10.67% | 10.5% |
| Announcement Date | 3/12/24 | - | - | - |
1EUR in Million2EUR
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
17
Last Close Price
94.26
EUR
Average target price
107.5
EUR
Spread / Average Target
+14.08%
EPS Revisions
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| +0.37% | 10.66B | |
| -2.06% | 73.82B | |
| +2.17% | 47.49B | |
| +2.24% | 32.7B | |
| +4.50% | 17.15B | |
| -6.71% | 11.92B | |
| +12.39% | 11.85B | |
| +9.00% | 9.76B | |
| -7.59% | 8.31B | |
| +4.76% | 8.2B |
- Stock Market
- Equities
- SYENS Stock
- Financials Syensqo SA/NV